19:11 , Mar 17, 2017 |  BC Week In Review  |  Financial News

eGenesis completes venture financing

On March 16, xenotransplantation company eGenesis Inc. (Boston, Mass.) raised the undisclosed first tranche of a planned $38 million series A round co-led by Biomatics Capital Partners and Arch Venture Partners . Khosla Ventures, Alta...
19:05 , Mar 17, 2017 |  BioCentury  |  Finance

CRISPR pigs

Drawn by CRISPR’s potential to address the organ transplant shortage with safer xenotransplants, Biomatics Capital Partners and Arch Venture Partners co-led a $38 million series A round for eGenesis Inc. intended to fund the company...
04:16 , Mar 16, 2017 |  BC Extra  |  Financial News

eGenesis raises $38M series A

Xenotransplantation play eGenesis Inc. (Boston, Mass.) raised the first tranche of a $38 million series A round co-led by Biomatics Capital Partners and Arch Venture Partners . Khosla Ventures, Alta Partners , Alexandria Real Estate...